- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Merck & Co Inc BDR (MRCK34)"Merck & Co Inc BDR stock price live, this page displays BVMF MRCK34 stock exchange data. View the MRCK34 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Merck & Co Inc BDR real time stock price chart below.
What Is the Merck & Co Inc BDR Stock Price Today?
The Merck & Co Inc BDR stock price today is 78.39.
What Is the Stock Symbol for Merck & Co Inc BDR?
The stock symbol for Merck & Co Inc BDR is ""MRCK34.""
What Stock Exchange Does Merck & Co Inc BDR Trade On?
Merck & Co Inc BDR is listed and trades on the B3 stock exchange.
Is Merck & Co Inc BDR a Good Stock to Buy?
Determining whether Merck & Co Inc BDR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRCK34 quote. (ISIN: BRMRCKBDR003)"
What Is the Merck & Co Inc BDR Stock Price Today?
The Merck & Co Inc BDR stock price today is 78.39.
What Is the Stock Symbol for Merck & Co Inc BDR?
The stock symbol for Merck & Co Inc BDR is ""MRCK34.""
What Stock Exchange Does Merck & Co Inc BDR Trade On?
Merck & Co Inc BDR is listed and trades on the B3 stock exchange.
Is Merck & Co Inc BDR a Good Stock to Buy?
Determining whether Merck & Co Inc BDR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRCK34 quote. (ISIN: BRMRCKBDR003)"
78.39
+0.42(+0.54%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
77.76
78.56
52 wk Range
62.15
93.57
MRCK34 Scorecard
Full Analysis
Has raised its dividend for 14 consecutive years
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
77.7678.56
52 wk Range
62.1593.57
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(2.03%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(2.03%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockMRCK34 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Merck & Co Inc BDR Company Profile
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. vIt has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications. It also has licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Compare MRCK34 to Peers and Sector
Metrics to compare | MRCK34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRCK34PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.6x | −3.0x | −0.7x | |
PEG Ratio | 0.13 | −0.03 | 0.00 | |
Price/Book | 5.9x | 0.6x | 2.6x | |
Price / LTM Sales | 4.1x | 1.4x | 3.2x | |
Upside (Analyst Target) | - | 243.5% | 44.1% | |
Fair Value Upside | Unlock | 41.7% | 8.2% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.79
Dividend Yield
2.03%
Industry Median 1.73%
Annualized payout
1.5819
Paid quarterly
5-Years Growth
-
Growth Streak
People Also Watch
FAQ
What Is the Merck Co Inc BDR (MRCK34) Stock Price Today?
The Merck Co Inc BDR stock price today is 78.39
What Stock Exchange Does Merck Co Inc BDR Trade On?
Merck Co Inc BDR is listed and trades on the B3 stock exchange.
What Is the Stock Symbol for Merck Co Inc BDR?
The stock symbol for Merck Co Inc BDR is "MRCK34."
Does Merck Co Inc BDR Pay Dividends? What’s The Current Dividend Yield?
The Merck Co Inc BDR dividend yield is 2.03%.
What Is the Merck Co Inc BDR Market Cap?
As of today, Merck Co Inc BDR market cap is 1.59T.
What is Merck Co Inc BDR Earnings Per Share?
The Merck Co Inc BDR EPS is 4.79.
From a Technical Analysis Perspective, Is MRCK34 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.